Navigation Links
Tumors use enzyme to recruit regulatory T-cells and suppress immune response
Date:8/16/2007

than 1 percent of the cells in a tumor or its draining lymph node led MCG researchers to look for a population of powerful allies within the immune system that could explain the suppressive impact. Tregs seemed like a good choice. The 2003 paper by Italian scientists, followed by a 2006 paper that showed nave T-cells exposed to IDO differentiated into Tregs, helped cement that some sort of relationship existed, prompting MCG researchers to further explore the relationship in a tumor animal model.

It?s only been in the last year or two that people have begun to realize Tregs spend most of their time in a sort of resting state where they have the potential to be suppressive but are not at that moment, says Dr. Munn. That would make sense, because you dont want your immune system always shut off.


'/>"/>
Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Radiofrequency Energy Cooks Tumors Without Surgery
3. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
4. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
5. New Technique For Benign Breast Tumors
6. Morphine may excite cancerous tumors
7. Benign eye tumors being treated
8. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
9. Same molecule found in meat, milk, tumors
10. Another Treatment Option for Benign Tumors
11. Understanding The Origin Of Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 2Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 3Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 4Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 5Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 6Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 7Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 8Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 2Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 3Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 4Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 5Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 6Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 8Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 9Reportlinker Adds Training Manikins - Global Trends 2Reportlinker Adds Training Manikins - Global Trends 3Reportlinker Adds Training Manikins - Global Trends 4Reportlinker Adds Training Manikins - Global Trends 5Promising Therapy for Prostate Cancer 49656 1Promising Therapy for Prostate Cancer 49656 2Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 1Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 2Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 3Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 4Sparta Systems Unveils TrackWise 28R 29 Clinical Quality Management Solution 49652 1Sparta Systems Unveils TrackWise 28R 29 Clinical Quality Management Solution 49652 2Sparta Systems Unveils TrackWise 28R 29 Clinical Quality Management Solution 49652 3